

Dr. Christopher Anderson
Urologist
1 Podcast on BackTable
Dr. Christopher Anderson is a urologist with Columbia University Irving Medical Center in New York City.
Learn from the experiences and expertise of Dr. Christopher Anderson and other leading voices in your specialty on the BackTable app.

Episode # 134 • 03 Nov 2023
The Role of Renal Mass Biopsy in Modern Urology
In this episode of BackTable Urology, Dr. Aditya Bagrodia and Dr. Christopher Anderson (Columbia University) discuss the diagnosis and workup of kidney cancer, including renal biopsy techniques.
More from Dr. Christopher Anderson
About
Christopher B. Anderson, MD, Associate Professor of Urology at Columbia University Medical Center, joined the Department of Urology in September 2015. He specializes in cancers of the bladder, prostate, kidney, testis and penis and performs both open and robotic surgeries. Dr. Anderson completed his medical degree from Northwestern University, completed his urology residency at Vanderbilt University, and then spent two years at Memorial Sloan Kettering Cancer Center as a fellow in urologic oncology. Following his residency, Dr. Anderson completed a urologic oncology fellowship at Memorial Sloan Kettering Cancer Center and obtained a Master of Public Health degree from Harvard University.
Dr. Anderson's research interests include factors that influence the quality of surgery, access to care for patients with bladder cancer, outcomes after robotic prostatectomy, and active surveillance strategies for men with prostate cancer. Dr. Anderson has published several peer-reviewed articles and was recognized as "Best Reviewer" in 2014 by The Journal of Urology and in 2016 by Cancer.
Dr. Anderson has clinical expertise in robotic prostatectomy for the treatment of prostate cancer, radical cystectomy with orthotopic neobladder for patients with bladder cancer, and partial nephrectomy for the treatment of kidney tumors. He also specializes in the multidisciplinary management of men with testicular cancer, including the use of primary and post-chemotherapy retroperitoneal lymph node dissection. He is currently the site leader for several clinical trials investigating the use of immunotherapy in patients with invasive and non-invasive bladder cancer.
Visit Columbia University Irving Medical Center to learn more about Dr. Christopher Anderson.
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.